Download FREE Report Sample
Download Free samplePhage therapy or viral phage therapy is the therapeutic use of bacteriophages to treat pathogenic bacterial infections. Bacteriophages, known as phages, are a form of viruses. Phages attach to bacterial cells, and inject a viral genome into the cell.
Bacteriophage Therapy Market contains market size and forecasts of Bacteriophage Therapy in Global, including the following market information:
Global Bacteriophage Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Bacteriophage Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bacteriophage Therapy include Armata Pharmaceuticals, Inc., Eliava Biopreparations Ltd., Pherecydes Pharma, Intralytix, Inc., Phagelux Inc., Nextbiotics, InnoPhage, Ltd, Locus Biosciences, Inc. and TechnoPhage, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Bacteriophage Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bacteriophage Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Bacteriophage Therapy Market Segment Percentages, by Type, 2021 (%)
Oral
Topical
Parenteral
Global Bacteriophage Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Bacteriophage Therapy Market Segment Percentages, by Application, 2021 (%)
Organ Transplantation
Bacterial Infections
Alcoholic Hepatitis
Other
Global Bacteriophage Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Bacteriophage Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bacteriophage Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Bacteriophage Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Armata Pharmaceuticals, Inc.
Eliava Biopreparations Ltd.
Pherecydes Pharma
Intralytix, Inc.
Phagelux Inc.
Nextbiotics
InnoPhage, Ltd
Locus Biosciences, Inc.
TechnoPhage
Eligo Bioscience SA
Phagomed Biopharma GmbH.
PhagePro, Inc.
Adaptive Phage Therapeutics, Inc.
EnBiotix, Inc.
Intodeworld, Inc.
BiomX Ltd.
Phi Therapeutics
Fixed-phage Ltd.
Micreos BV
ContraFect Corporation
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy